AAV5 Vector and Uses Thereof

The invention described and claimed in this patent application provides for novel vectors and viral particles which comprise adeno-associated virus serotype 5 (AAV5). AAV5 is a single-stranded DNA virus of either plus or minus polarity which, like other AAV serotypes (e.g., AAV4, AAV2) requires a helper virus for replication. AAV type 2 has the interesting and potentially useful ability to integrate into human chromosome 19 q 13.3-q ter. This activity is dependent on the non-structural, Rep, proteins of AAV2. The Rep proteins of AAV types 2 and 5 are dissimilar and are not able to substitute in DNA replication of the heterologous serotype. AAV5 offers several advantages which make it attractive for use in gene therapy: 1. increased production (10-50 fold greater than AAV2); 2. distinct integration locus when compared to AAV2; 3. Rep protein and ITR regions do not complement other AAV serotypes; and 4. appears to utilize different cell surface attachment molecules than those of AAV type 2.

Related Invention(s):


John Chiorini (NHLBI)  ➽ more inventions...

Robert Kotin (NHLBI)  ➽ more inventions...

Intellectual Property:
US Pat: 7,479,554 issued 2009-01-20
US Pat: 6,984,517 issued 2006-01-10
PCT Application No. PCT/US99/11958 filed on 1999-05-28
US Application No. 60/087,029 filed on 1998-05-28

Chiorini JA, et al. PMID 10196327
Chiorini JA, et al. PMID 9882336

Licensing Contact:
John Devany,
Email: john.devany@nih.gov
Phone: 301-594-4090

OTT Reference No: E-127-1998-0
Updated: May 9, 2018